ZA977254B - Dosage form for providing ascending dose of drug. - Google Patents

Dosage form for providing ascending dose of drug.

Info

Publication number
ZA977254B
ZA977254B ZA9707254A ZA977254A ZA977254B ZA 977254 B ZA977254 B ZA 977254B ZA 9707254 A ZA9707254 A ZA 9707254A ZA 977254 A ZA977254 A ZA 977254A ZA 977254 B ZA977254 B ZA 977254B
Authority
ZA
South Africa
Prior art keywords
dosage form
drug
ascending dose
providing ascending
providing
Prior art date
Application number
ZA9707254A
Other languages
English (en)
Inventor
Padmaja Shivanand
Atul D Ayer
Jeri D Wright
Andrew Lam
Lawrence G Hamel
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21814183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA977254(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of ZA977254B publication Critical patent/ZA977254B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
ZA9707254A 1996-08-16 1997-08-13 Dosage form for providing ascending dose of drug. ZA977254B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2328696P 1996-08-16 1996-08-16

Publications (1)

Publication Number Publication Date
ZA977254B true ZA977254B (en) 1998-05-11

Family

ID=21814183

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9707254A ZA977254B (en) 1996-08-16 1997-08-13 Dosage form for providing ascending dose of drug.

Country Status (13)

Country Link
EP (1) EP0957899B1 (cg-RX-API-DMAC7.html)
JP (1) JP4393587B2 (cg-RX-API-DMAC7.html)
CN (2) CN101518517B (cg-RX-API-DMAC7.html)
AT (1) ATE234602T1 (cg-RX-API-DMAC7.html)
AU (1) AU3909597A (cg-RX-API-DMAC7.html)
CA (1) CA2263558A1 (cg-RX-API-DMAC7.html)
CY (1) CY2475B1 (cg-RX-API-DMAC7.html)
DE (1) DE69720055T2 (cg-RX-API-DMAC7.html)
DK (1) DK0957899T3 (cg-RX-API-DMAC7.html)
ES (1) ES2194210T3 (cg-RX-API-DMAC7.html)
PT (1) PT957899E (cg-RX-API-DMAC7.html)
WO (1) WO1998006380A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA977254B (cg-RX-API-DMAC7.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
CA2264852C (en) * 1996-09-30 2005-11-01 Alza Corporation Use of methylphenidate or a pharmaceutically acceptable salt thereof
EP1690531A3 (en) * 1996-09-30 2010-01-20 Alza Corporation Dosage form and method for administering drug
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
PT946151E (pt) * 1996-11-25 2006-07-31 Alza Corp Forma de dosagem de dose crescente
US6962997B1 (en) 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
AU2012232984B2 (en) * 1998-06-03 2015-10-29 Alza Corporation Methods and devices for providing prolonged drug therapy
KR100890537B1 (ko) * 1998-06-03 2009-03-27 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치
KR100827254B1 (ko) 1998-06-03 2008-05-07 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치
AU2004200938B2 (en) * 1998-06-03 2006-09-14 Alza Corporation Methods and devices for providing prolonged drug therapy
HK1046638B (zh) * 1998-06-03 2006-02-24 阿尔扎有限公司 提供药物长效治疗的方法和装置
DK1126826T6 (en) 1998-11-02 2019-06-24 Alkermes Pharma Ireland Ltd Multiparticulate modified release of methylphenidate
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6673367B1 (en) * 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
US6340476B1 (en) 1999-04-06 2002-01-22 Armaquest, Inc. Pharmaceutical dosage form for pulsatile delivery of methylphenidate
HK1053060A1 (zh) * 2000-01-20 2003-10-10 德尔西斯药品公司 多级药物剂型
CN1684670A (zh) * 2002-07-29 2005-10-19 阿尔扎公司 用于控制释放帕潘立酮的方法和剂型
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
AU2003287301A1 (en) * 2002-10-31 2004-06-07 Alza Corporation Dosage form providing ascending release of liquid formulation
US7988993B2 (en) 2002-12-09 2011-08-02 Andrx Pharmaceuticals, Inc. Oral controlled release dosage form
MXPA06003452A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Formulaciones de liberacion controlada que exhiben una velocidad de liberacion ascendente.
US8246986B2 (en) 2003-09-26 2012-08-21 Alza Corporation Drug coating providing high drug loading
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
PL116330U1 (en) 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
JP2011511782A (ja) 2008-02-12 2011-04-14 アボット・ラボラトリーズ 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
WO2015001488A1 (en) 2013-07-01 2015-01-08 Ranbaxy Laboratories Limited Extended-release tablets of paliperidone and processes of preparation thereof
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
WO2017115328A1 (en) * 2015-12-31 2017-07-06 Cadila Healthcare Limited Extended release osmotic dosage form comprising high methylphenidate hydrochloride load
EP3501504A1 (en) 2017-12-22 2019-06-26 Pharmacia Polonica sp. z o.o. Modified release tablet of paliperidone and a process for the preparation thereof
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
GB2206046B (en) * 1987-06-25 1991-04-03 Alza Corp Multi-unit delivery system
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US5017381A (en) * 1990-05-02 1991-05-21 Alza Corporation Multi-unit pulsatile delivery system
DE69425453T2 (de) * 1993-04-23 2001-04-12 Novartis Ag, Basel Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
CA2263558A1 (en) 1998-02-19
CY2475B1 (en) 2005-06-03
PT957899E (pt) 2003-07-31
EP0957899B1 (en) 2003-03-19
DK0957899T3 (da) 2003-04-22
JP2000516610A (ja) 2000-12-12
CN100484518C (zh) 2009-05-06
CN101518517B (zh) 2014-11-26
JP4393587B2 (ja) 2010-01-06
AU3909597A (en) 1998-03-06
WO1998006380A3 (en) 1998-05-14
CN1228691A (zh) 1999-09-15
HK1021886A1 (zh) 2000-07-14
EP0957899A2 (en) 1999-11-24
HK1137355A1 (zh) 2010-07-30
ES2194210T3 (es) 2003-11-16
DE69720055T2 (de) 2003-09-11
CN101518517A (zh) 2009-09-02
WO1998006380A2 (en) 1998-02-19
DE69720055D1 (de) 2003-04-24
ATE234602T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
CY2475B1 (en) Dosage form for providing ascending dose of drug.
AU5267698A (en) Ascending-dose dosage form
WO1994027589A3 (en) Antidepressant dosage form
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
WO1998014168A3 (en) Dosage form providing a sustained and ascending drug release
GB2303064B (en) Medicament for nasal administration
EP1001772A4 (en) IMPROVEMENTS IN THE ADMINISTRATION OF MULTIPLE DRUG DOSAGES
AU1534699A (en) Osmotic dosage form comprising first and second coats
EP0745401A3 (en) Medication inhaler
AU6060896A (en) Oral 1alpha-hydroxyprevitamin D
NZ508526A (en) Opioid formulations for treating pain
GEP20002229B (en) Synthetic Membrane Vesicles, Method for Obtaining and Application of the Same
NZ229518A (en) Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment
RO116771B1 (ro) Metodă pentru prevenirea sau tratamentul dependenţei, toleranţei sau abuzului de benzodiazepine
ZA968905B (en) Transdermal therapeutic system (tts) for administering active substances for drug dependence or drug addiction
PL325242A1 (en) Method of obtaining solid drug administration forms for very low dosage drugs
IL116615A0 (en) A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole and of salts thereof
GB9304549D0 (en) Apparatus for administration of drugs
MX9605190A (es) Forma de dosis efectiva para farmacos antiepilepticos.
ZA977873B (en) Dosage form and method for administering drug.
GB8808995D0 (en) Apparatus for oral administration of medicament
GB9218422D0 (en) Device for administering single doses of medicament
GB9301351D0 (en) An improved method of drug administration
IT1269412B (it) Apparecchio distributore di farmaci
UA30251A (uk) Спосіб лікування гіпертонії сфінктера одді у хворих на хронічний безкам'яний холецистит при поєднанні з підвищенням тонусу симпатичної нервової системи